Update on IgG4-mediated autoimmune diseases: New insights and new family members

Koneczny, 2018, A new classification system for IgG4 autoantibodies, Front Immunol, 9, 10.3389/fimmu.2018.00097 Huijbers, 2015, The expanding field of IgG4-mediated neurological autoimmune disorders, Eur J Neurol, 22, 1151, 10.1111/ene.12758 Kridin, 2017, Mortality and cause of death in patients with pemphigus, Acta Derm Venereol, 97, 607, 10.2340/00015555-2611 Niks, 2007, Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands, J Neurol Neurosurg Psychiatry, 78, 417, 10.1136/jnnp.2006.102517 Carr, 2010, A systematic review of population based epidemiological studies in myasthenia gravis, BMC Neurol, 10, 46, 10.1186/1471-2377-10-46 Broers, 2019, Incidence and prevalence of chronic inflammatory demyelinating Polyradiculoneuropathy: a systematic review and meta-analysis, Neuroepidemiology, 52, 161, 10.1159/000494291 Cortese, 2020, Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype, Neurol Neuroimmunol Neuroinflam, 7, 10.1212/NXI.0000000000000639 Hubner, 2016, Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany, J Invest Dermatol, 136, 2495, 10.1016/j.jid.2016.07.013 Schmidt, 2019, Pemphigus, Lancet, 394, 882, 10.1016/S0140-6736(19)31778-7 Hu, 2017, GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia, J Clin Lipidol, 11, 964, 10.1016/j.jacl.2017.05.017 Beigneux, 2017, Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia, N Engl J Med, 376, 1647, 10.1056/NEJMoa1611930 Koneczny, 2019 Duan, 2019, Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity, Acta Neuropathol Commun, 7, 112, 10.1186/s40478-019-0766-7 Diny, 2017, Eosinophils in autoimmune diseases, Front Immunol, 8, 484, 10.3389/fimmu.2017.00484 Wener, 2011, Immune Complexes in Systemic Lupus Erythematosus, 321 Drachman, 1978, Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation, N Engl J Med, 298, 1116, 10.1056/NEJM197805182982004 Heinemann, 1977, Modulation of acetylcholine receptor by antibody against the receptor, Proc Natl Acad Sci U S A, 74, 3090, 10.1073/pnas.74.7.3090 Sabater, 2016, Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome, J Neuroinflammation, 13, 226, 10.1186/s12974-016-0689-1 Carvajal-Gonzalez, 2014, Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes, Brain, 137, 2178, 10.1093/brain/awu142 Hughes, 2010, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis, J Neurosci, 30, 5866, 10.1523/JNEUROSCI.0167-10.2010 Barcellini, 2015, New insights in the pathogenesis of autoimmune hemolytic Anemia, Transfusion Med Hemother, 42, 287, 10.1159/000439002 Ludwig, 2017, Mechanisms of autoantibody-induced pathology, Front Immunol, 8, 603, 10.3389/fimmu.2017.00603 Sadler, 2017, Pathophysiology of thrombotic thrombocytopenic purpura, Blood, 130, 1181, 10.1182/blood-2017-04-636431 Rapoport, 2007, The thyrotropin receptor in Graves’ disease, Thyroid, 17, 911, 10.1089/thy.2007.0170 Rapoport, 1998, The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies, Endocr Rev, 19, 673 Koneczny, 2013, MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters, PLoS One, 8, 10.1371/journal.pone.0080695 Kasperkiewicz, 2017, Pemphigus, Nat Rev Dis Primers, 3, 17026, 10.1038/nrdp.2017.26 Lichtenstein, 1968, A quantitative in vitro study of the chromatographic distribution and immunoglobulin characteristics of human blocking antibody, J Immunol, 101, 317, 10.4049/jimmunol.101.2.317 Aalberse, 1983, Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response, J Immunol, 130, 722, 10.4049/jimmunol.130.2.722 Nakagawa, 1985, The role of IgG4 as blocking antibodies in asthmatics and in bee keepers, Int Arch Allergy Appl Immunol, 77, 204, 10.1159/000233787 Platts-Mills, 2001, Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study, Lancet, 357, 752, 10.1016/S0140-6736(00)04168-4 Pinck, 1967, Disulphide bridges of a human immunoglobulin G protein, Nature, 216, 941, 10.1038/216941a0 Frangione, 1967, Disulphide bridges of immunoglobin G-1 heavy chains, Nature, 216, 939, 10.1038/216939b0 Frangione, 1969, Structural studies of immunoglobulin G, Nature, 221, 145, 10.1038/221145a0 Tian, 2015, In-depth analysis of subclass-specific conformational preferences of IgG antibodies, IUCrJ, 2, 9, 10.1107/S205225251402209X Konig, 2017, Antibodies under pressure: a small-angle X-ray scattering study of immunoglobulin G under high hydrostatic pressure, Biophys Chem, 231, 45, 10.1016/j.bpc.2017.05.016 Schroeder, 2010, Structure and function of immunoglobulins, J Allergy Clin Immunol, 125, S41, 10.1016/j.jaci.2009.09.046 Lu, 2007, Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation, Biophys J, 93, 3733, 10.1529/biophysj.107.108993 Abe, 2010, Masking of the fc region in human IgG4 by constrained X-ray scattering modelling: implications for antibody function and therapy, Biochem J, 432, 101, 10.1042/BJ20100641 Diebolder, 2014, Complement is activated by IgG hexamers assembled at the cell surface, Science, 343, 1260, 10.1126/science.1248943 Lhotta, 1999, Glomerular deposition of mannose-binding lectin in human glomerulonephritis, Nephrol Dial Transplant, 14, 881, 10.1093/ndt/14.4.881 Yang, 2016, IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study, Immunol Res, 64, 919, 10.1007/s12026-016-8790-1 Segawa, 2010, IgG subclasses and complement pathway in segmental and global membranous nephropathy, Pediatr Nephrol, 25, 1091, 10.1007/s00467-009-1439-8 Ma, 2011, Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway (abstract), J Am Soc Nephrol, 22, 62A Hayashi, 2017, Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy, Nephrol Dial Transplant, 33, 832, 10.1093/ndt/gfx235 Beck, 2014, Membranous nephropathy: from models to man, J Clin Invest, 124, 2307, 10.1172/JCI72270 Malhotra, 1995, Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein, Nat Med, 1, 237, 10.1038/nm0395-237 Roos, 2001, Human IgA activates the complement system via the mannan-binding lectin pathway, J Immunol, 167, 2861, 10.4049/jimmunol.167.5.2861 Tao, 1993, Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation, J Exp Med, 178, 661, 10.1084/jem.178.2.661 Brekke, 1994, Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis, Eur J Immunol, 24, 2542, 10.1002/eji.1830241042 Canfield, 1991, The binding affinity of human IgG for its high affinity fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region, J Exp Med, 173, 1483, 10.1084/jem.173.6.1483 Sondermann, 2000, The 3.2-a crystal structure of the human IgG1 fc fragment-fc gammaRIII complex, Nature, 406, 267, 10.1038/35018508 Shields, 2001, High resolution mapping of the binding site on human IgG1 for fc gamma RI, fc gamma RII, fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the fc gamma R, J Biol Chem, 276, 6591, 10.1074/jbc.M009483200 Radaev, 2001, The structure of a human type III Fcgamma receptor in complex with fc, J Biol Chem, 276, 16469, 10.1074/jbc.M100350200 Davies, 2013, Crystal structure of the human IgG4 C(H)3 dimer reveals the role of Arg409 in the mechanism of fab-arm exchange, Mol Immunol, 54, 1, 10.1016/j.molimm.2012.10.029 Labrijn, 2011, Species-specific determinants in the IgG CH3 domain enable fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength, J Immunol, 187, 3238, 10.4049/jimmunol.1003336 Blech, 2019, Structure of a therapeutic full-length anti-NPRA IgG4 antibody: dissecting conformational diversity, Biophys J, 116, 1637, 10.1016/j.bpj.2019.03.036 Schuurman, 2001, The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds, Mol Immunol, 38, 1, 10.1016/S0161-5890(01)00050-5 Bloom, 1997, Intrachain disulfide bond in the core hinge region of human IgG4, Protein Sci, 6, 407, 10.1002/pro.5560060217 Angal, 1993, A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody, Mol Immunol, 30, 105, 10.1016/0161-5890(93)90432-B King, 1992, Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab’ fragment, Biochem J, 281, 317, 10.1042/bj2810317 Margni, 1988, Nonprecipitating asymmetric antibodies, Annu Rev Immunol, 6, 535, 10.1146/annurev.iy.06.040188.002535 van der Zee, 1986, Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency, J Immunol, 137, 3566, 10.4049/jimmunol.137.11.3566 Petersen, 1974, An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G, J Biol Chem, 249, 5633, 10.1016/S0021-9258(20)79774-7 Colcher, 1989, Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3, Cancer Res, 49, 1738 van der Neut Kolfschoten, 2007, Anti-inflammatory activity of human IgG4 antibodies by dynamic fab arm exchange, Science, 317, 1554, 10.1126/science.1144603 Rispens, 2014, Dynamics of inter-heavy chain interactions in human immunoglobulin G (IgG) subclasses studied by kinetic fab arm exchange, J Biol Chem, 289, 6098, 10.1074/jbc.M113.541813 Young, 2014, Estimation of polyclonal IgG4 hybrids in normal human serum, Immunology, 142, 406, 10.1111/imm.12265 Koneczny, 2017, IgG4 autoantibodies against muscle-specific kinase undergo fab-arm exchange in myasthenia gravis patients, J Autoimmun, 77, 104, 10.1016/j.jaut.2016.11.005 Aalberse, 2009, Immunoglobulin G4: an odd antibody, Clin Exp Allergy, 39, 469, 10.1111/j.1365-2222.2009.03207.x Collins, 2013, Enhanced cell-binding by allergen multimers: how complex is it?, Immunol Cell Biol, 91, 115, 10.1038/icb.2013.5 van der Zee, 1986, Inhibition of complement activation by IgG4 antibodies, Clin Exp Immunol, 64, 415 Davies, 2014, Structural determinants of unique properties of human IgG4-fc, J Mol Biol, 426, 630, 10.1016/j.jmb.2013.10.039 Rispens, 2009, Human IgG4 binds to IgG4 and conformationally altered IgG1 via fc-fc interactions, J Immunol, 182, 4275, 10.4049/jimmunol.0804338 Zack, 1995, Localization of an fc-binding reactivity to the constant region of human IgG4. Implications for the pathogenesis of rheumatoid arthritis, J Immunol, 155, 5057, 10.4049/jimmunol.155.10.5057 Kawa, 2008, A novel immunoglobulin-immunoglobulin interaction in autoimmunity, PLoS One, 3, 10.1371/journal.pone.0001637 Cohen, 1987, The subclass distribution of human IgG rheumatoid factor, J Immunol, 139, 1466, 10.4049/jimmunol.139.5.1466 Detlefsen, 2010, Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis, Histopathology, 57, 825, 10.1111/j.1365-2559.2010.03717.x Ma, 2013, The role of complement in membranous nephropathy, Semin Nephrol, 33, 531, 10.1016/j.semnephrol.2013.08.004 Rees-Roberts, 2010, Inactivation of the complement anaphylatoxin C5a by secreted products of parasitic nematodes, Int J Parasitol, 40, 527, 10.1016/j.ijpara.2009.10.006 Maizels, 2003, Immune regulation by helminth parasites: cellular and molecular mechanisms, Nat Rev Immunol, 3, 733, 10.1038/nri1183 Babu, 2006, Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence, J Immunol, 176, 3248, 10.4049/jimmunol.176.5.3248 Adjobimey, 2010, Induction of immunoglobulin G4 in human filariasis: an indicator of immunoregulation, Ann Trop Med Parasitol, 104, 455, 10.1179/136485910X12786389891407 Prodjinotho, 2019, IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a fc-fc-dependent mechanism, Parasitol Res, 118, 2957, 10.1007/s00436-019-06451-2 Vidarsson, 2014, IgG subclasses and allotypes: from structure to effector functions, Front Immunol, 5, 520, 10.3389/fimmu.2014.00520 Nirula, 2011, What is IgG4? A review of the biology of a unique immunoglobulin subtype, Curr Opin Rheumatol, 23, 119, 10.1097/BOR.0b013e3283412fd4 Lighaam, 2016, The Immunobiology of immunoglobulin G4, Semin Liver Dis, 36, 200, 10.1055/s-0036-1584322 Van der Zee, 1987, IgG4 and hyposensitization, N Engl Reg Allergy Proc, 8, 389, 10.2500/108854187778999667 Margni, 1980, Immunobiological behaviour of rabbit precipitating and non-precipitating (co-precipitating) antibodies, Immunology, 41, 681 van Toorenenbergen, 1982, IgG4 and release of histamine from human peripheral blood leukocytes, Int Arch Allergy Appl Immunol, 67, 117, 10.1159/000233000 Aalberse, 1983, IgG4 as a blocking antibody, Clin Rev Allergy, 1, 289, 10.1007/BF02991163 James, 2012, Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy, J Allergy Clin Immunol, 130, 663, 10.1016/j.jaci.2012.04.006 Santos, 2015, IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens, J Allergy Clin Immunol, 135, 1249, 10.1016/j.jaci.2015.01.012 Kemeny, 1983, Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens, J Allergy Clin Immunol, 72, 376, 10.1016/0091-6749(83)90503-1 Kemeny, 1983, Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy, Monogr Allergy, 18, 150 Resende, 2019, IgE, IgG1, and IgG4 reactivity to Dermatophagoides pteronyssinus glycosylated extract in allergic patients, Biomed Res Int, 2019, 9840890, 10.1155/2019/9840890 Subbarayal, 2013, Kinetics, cross-reactivity, and specificity of bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen, Allergy, 68, 1377, 10.1111/all.12236 van Neerven, 1999, Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation, J Immunol, 163, 2944, 10.4049/jimmunol.163.5.2944 Bodtger, 2005, Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?, Int Arch Allergy Immunol, 136, 340, 10.1159/000084227 Crescioli, 2016, IgG4 characteristics and functions in Cancer immunity, Curr Allergy Asthma Rep, 16, 7, 10.1007/s11882-015-0580-7 Lopes, 2016, Helminth regulation of immunity: a three-pronged approach to treat colitis, Inflamm Bowel Dis, 22, 2499, 10.1097/MIB.0000000000000889 Maizels, 2019, Regulation of immunity and allergy by helminth parasites, Allergy, 75, 524, 10.1111/all.13944 Elliott, 2012, Helminth-host immunological interactions: prevention and control of immune-mediated diseases, Ann N Y Acad Sci, 1247, 83, 10.1111/j.1749-6632.2011.06292.x Marple, 2017, Cutting edge: helminth coinfection blocks effector differentiation of CD8 T cells through alternate host Th2- and IL-10-mediated responses, J Immunol, 198, 634, 10.4049/jimmunol.1601741 Boctor, 1990, IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4, Clin Exp Immunol, 82, 574, 10.1111/j.1365-2249.1990.tb05492.x Satoguina, 2008, Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta, Eur J Immunol, 38, 3101, 10.1002/eji.200838193 Tang, 2019, Helminths protect against type 1 diabetes: effects and mechanisms, Parasitol Res, 118, 1087, 10.1007/s00436-019-06247-4 Shen, 2015, Suppressive functions of B cells in infectious diseases, Int Immunol, 27, 513, 10.1093/intimm/dxv037 Chapuy-Regaud, 2005, IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin, Clin Exp Immunol, 139, 542, 10.1111/j.1365-2249.2004.02708.x Panza, 2014, Immunoglobulin G subclass profile of anticitrullinated peptide antibodies specific for Epstein Barr virus-derived and histone-derived citrullinated peptides, J Rheumatol, 41, 407, 10.3899/jrheum.130795 Lundstrom, 2014, IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, fc-glycans and a fab-peptide sequence, PLoS One, 9, 10.1371/journal.pone.0113924 Engelmann, 2018, Decreased IgG4 ACPA levels in responders and increased CD1c(+) classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy, Clin Rheumatol, 37, 1783, 10.1007/s10067-018-4053-y Bos, 2009, Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis, Ann Rheum Dis, 68, 558, 10.1136/ard.2008.088401 Pan, 2017, Nature, functions, and clinical implications of IgG4 autoantibodies in systemic lupus erythematosus and rheumatoid arthritis, Discov Med, 23, 169 van de Stadt, 2014, Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation, Arthritis Rheum, 66, 1133, 10.1002/art.38335 Falkenburg, 2017, Anti-hinge antibodies recognize IgG subclass- and protease-restricted Neoepitopes, J Immunol, 198, 82, 10.4049/jimmunol.1601096 Umehara, 2019, The front line of research into immunoglobin G4-related disease - do autoantibodies cause immunoglobin G4-related disease?, Mod Rheumatol, 29, 214, 10.1080/14397595.2018.1558519 Watanabe, 2018, Mechanistic insights into autoimmune pancreatitis and IgG4-related disease, Trends Immunol, 39, 874, 10.1016/j.it.2018.09.005 Pagliari, 2019, Autoimmune pancreatitis in children: the impact of immune system in a challenging disease, Autoimmun Rev, 18, 209, 10.1016/j.autrev.2018.09.006 Akiyama, 2019, Characteristics and prognosis of IgG4-related periaortitis/periarteritis: a systematic literature review, Autoimmun Rev, 18, 102354, 10.1016/j.autrev.2019.102354 Morales, 2019, An update on IgG4-related lung disease, Eur J Intern Med, 66, 18, 10.1016/j.ejim.2019.06.010 Romano, 2019, Autoimmune phenomena involving the pituitary gland in children: new developing data about diagnosis and treatment, Autoimmun Rev, 18, 102363, 10.1016/j.autrev.2019.102363 Stone, 2012, IgG4-related disease: nomenclature, clinical features, and treatment, Semin Diagn Pathol, 29, 177, 10.1053/j.semdp.2012.08.002 Umehara, 2017, How to diagnose IgG4-related disease, Ann Rheum Dis, 76, 10.1136/annrheumdis-2017-211330 Bozzalla Cassione, 2017, IgG4-related disease, Curr Opin Rheumatol, 29, 223, 10.1097/BOR.0000000000000383 Shiokawa, 2016, Pathogenicity of IgG in patients with IgG4-related disease, Gut, 65, 1322, 10.1136/gutjnl-2015-310336 Hubers, 2018, Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease, Gut, 67, 728 Perugino, 2019, Identification of galectin-3 as an autoantigen in patients with IgG4-related disease, J Allergy Clin Immunol, 143, 736, 10.1016/j.jaci.2018.05.011 Yamada, 2018, LatY136F knock-in mouse model for human IgG4-related disease, PLoS One, 13, 10.1371/journal.pone.0198417 Witebsky, 1957, Chronic thyroiditis and autoimmunization, JAMA, 164, 1439, 10.1001/jama.1957.02980130015004 Rose, 1993, Defining criteria for autoimmune diseases(Witebsky’s postulates revisited), Immunol Today, 14, 426, 10.1016/0167-5699(93)90244-F Naparstek, 1993, The role of autoantibodies in autoimmune disease, Annu Rev Immunol, 11, 79, 10.1146/annurev.iy.11.040193.000455 Hoch, 2001, Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, Nat Med, 7, 365, 10.1038/85520 McConville, 2004, Detection and characterization of MuSK antibodies in seronegative myasthenia gravis, Ann Neurol, 55, 580, 10.1002/ana.20061 Huijbers, 2016, Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity, J Neuroimmunol, 291, 82, 10.1016/j.jneuroim.2015.12.016 Takamori, 2013, Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis, J Neuroimmunol, 254, 183, 10.1016/j.jneuroim.2012.09.001 Otsuka, 2015, Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling, Sci Rep, 5, 13928, 10.1038/srep13928 Zhang, 2011, Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK), J Biol Chem, 286, 40624, 10.1074/jbc.M111.279307 Huijbers, 2013, MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4, Proc Natl Acad Sci U S A, 110, 20783, 10.1073/pnas.1313944110 Koneczny, 2014, Potential mechanisms in MuSK myasthenia gravis Huijbers, 2019, MuSK myasthenia gravis monoclonal antibodies: Valency dictates pathogenicity, Neurol Neuroimmunol Neuroinflam, 6, e547, 10.1212/NXI.0000000000000547 Mori, 2012, Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis, Am J Pathol, 180, 798, 10.1016/j.ajpath.2011.10.031 Morsch, 2012, Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors, Exp Neurol, 237, 286, 10.1016/j.expneurol.2012.06.034 Selcen, 2004, Are MuSK antibodies the primary cause of myasthenic symptoms?, Neurology, 62, 1945, 10.1212/01.WNL.0000128048.23930.1D Viegas, 2012, Passive and active immunization models of MuSK-ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects, Exp Neurol, 234, 506, 10.1016/j.expneurol.2012.01.025 Niks, 2010, Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia, Muscle Nerve, 42, 283, 10.1002/mus.21642 Yumoto, 2012, Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses, Nature, 489, 438, 10.1038/nature11348 Wu, 2012, Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation, Neuron, 75, 94, 10.1016/j.neuron.2012.04.033 Sabre, 2019, Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis, J Neurol Sci, 399, 15, 10.1016/j.jns.2019.02.001 Faivre-Sarrailh, 2013, Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases, Front Cell Neurosci, 7, 196, 10.3389/fncel.2013.00196 Peles, 1997, Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions, EMBO J, 16, 978, 10.1093/emboj/16.5.978 Rios, 2000, Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination, J Neurosci, 20, 8354, 10.1523/JNEUROSCI.20-22-08354.2000 Charles, 2002, Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction, Curr Biol, 12, 217, 10.1016/S0960-9822(01)00680-7 Doppler, 2016, Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy, Brain, 139, 2617, 10.1093/brain/aww189 Querol, 2012, Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy, Ann Neurol, 3, 370 Miura, 2015, Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia, Brain, 138, 1484, 10.1093/brain/awv054 Doppler, 2015, Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies, J Neurol Neurosurg Psychiatry, 86, 720, 10.1136/jnnp-2014-309916 Labasque, 2014, Specific contactin N-glycans are implicated in neurofascin binding and autoimmune targeting in peripheral neuropathies, J Biol Chem, 289, 7907, 10.1074/jbc.M113.528489 Sistani, 2013, Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation, Kidney Int, 83, 63, 10.1038/ki.2012.321 Reid, 1994, Identification and characterization of the human cell adhesion molecule contactin, Brain Res Mol Brain Res, 21, 1, 10.1016/0169-328X(94)90372-7 Taieb, 2019, “neuro-renal syndrome” related to anti-contactin-1 antibodies, Muscle Nerve, 59, E19, 10.1002/mus.26392 Doppler, 2019, Anti-CNTN1 IgG3 induces acute conduction block and motor deficits in a passive transfer rat model, J Neuroinflammation, 16, 73, 10.1186/s12974-019-1462-z Kanigicherla, 2013, Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy, Kidney Int, 83, 940, 10.1038/ki.2012.486 Manso, 2016, Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects, Brain, 139, 1700, 10.1093/brain/aww062 Bhat, 2001, Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin, Neuron, 30, 369, 10.1016/S0896-6273(01)00294-X Boyle, 2001, Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve, Neuron, 30, 385, 10.1016/S0896-6273(01)00296-3 Sherman, 2005, Neurofascins are required to establish axonal domains for saltatory conduction, Neuron, 48, 737, 10.1016/j.neuron.2005.10.019 Ng, 2012, Neurofascin as a target for autoantibodies in peripheral neuropathies, Neurology, 79, 2241, 10.1212/WNL.0b013e31827689ad Devaux, 2016, Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy, Neurology, 86, 800, 10.1212/WNL.0000000000002418 Kadoya, 2016, IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay, J Neuroimmunol, 301, 16, 10.1016/j.jneuroim.2016.10.013 Painous, 2018, Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient, Ann Clin Transl Neurol, 5, 499, 10.1002/acn3.539 Querol, 2015, Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins, Neurol Neuroimmunol Neuroinflamm, 2, 10.1212/NXI.0000000000000149 Bailly, 2018, Tremor associated with chronic inflammatory demyelinating polyneuropathy and anti-Neurofascin-155 antibodies, Tremor Other Hyperkinet Mov, 8, 606, 10.5334/tohm.451 Briani, 2019, Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy, J Neuroimmunol, 330, 178, 10.1016/j.jneuroim.2019.01.017 Manso, 2019, Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo, J Clin Invest, 130 Dutta, 2018, Regulation of myelin structure and conduction velocity by perinodal astrocytes, Proc Natl Acad Sci U S A, 115, 11832, 10.1073/pnas.1811013115 Thomas, 2015, Pathogenicity of anti-ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic Purpura, Ebiomedicine, 2, 942, 10.1016/j.ebiom.2015.06.007 Tsai, 1998, Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203 Schaller, 2014, The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs, Blood, 124, 3469, 10.1182/blood-2014-04-561142 Sinkovits, 2018, Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic Purpura, Front Immunol, 9, 1646, 10.3389/fimmu.2018.01646 Kremer Hovinga, 2017, Thrombotic thrombocytopenic purpura, Nat Rev Dis Primers, 3, 17020, 10.1038/nrdp.2017.20 Ostertag, 2016, ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model, Transfusion, 56, 1775, 10.1111/trf.13583 Stanley, 2006, Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome, N Engl J Med, 355, 1800, 10.1056/NEJMra061111 Amagai, 2003, Desmoglein as a target in autoimmunity and infection, J Am Acad Dermatol, 48, 244, 10.1067/mjd.2003.7 Di Zenzo, 2012, Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface, J Clin Invest, 122, 3781, 10.1172/JCI64413 Li, 2003, The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem), J Exp Med, 197, 1501, 10.1084/jem.20022031 Futei, 2001, Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus, J Dermatol Sci, 26, 55, 10.1016/S0923-1811(00)00158-4 Rock, 1989, The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem), N Engl J Med, 320, 1463, 10.1056/NEJM198906013202206 Payne, 2005, Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display, J Clin Invest, 115, 888, 10.1172/JCI24185 Ishii, 2005, In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris, J Invest Dermatol, 124, 939, 10.1111/j.0022-202X.2005.23714.x Saito, 2012, Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation, PLoS One, 7, 10.1371/journal.pone.0050696 Evangelista, 2018, Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope, J Autoimmun, 89, 171, 10.1016/j.jaut.2017.12.017 Waschke, 2006, Inhibition of rho a activity causes pemphigus skin blistering, J Cell Biol, 175, 721, 10.1083/jcb.200605125 Li, 2009, Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin, J Immunol, 182, 711, 10.4049/jimmunol.182.1.711 Cipolla, 2017, Crosstalk between signaling pathways in pemphigus: a role for endoplasmic reticulum stress in p38 mitogen-activated protein kinase activation?, Front Immunol, 8, 1022, 10.3389/fimmu.2017.01022 Egu, 2017, Inhibition of p38MAPK signaling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis, Br J Dermatol, 6, 1612, 10.1111/bjd.15721 Mavropoulos, 2013, p38 MAPK signaling in pemphigus: implications for skin autoimmunity, Autoimmune Dis, 2013, 728529 Spindler, 2010, Protective endogenous cyclic adenosine 5′-monophosphate signaling triggered by pemphigus autoantibodies, J Immunol, 185, 6831, 10.4049/jimmunol.1002675 Walter, 2017, Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus, Sci Rep, 7, 3579, 10.1038/s41598-017-03697-7 Funakoshi, 2012, Enrichment of total serum IgG4 in patients with pemphigus, Br J Dermatol, 167, 1245, 10.1111/j.1365-2133.2012.11144.x Zhao, 2016, Neonatal autoimmune blistering disease: a systematic review, Pediatr Dermatol, 33, 367, 10.1111/pde.12859 Tsunoda, 2003, Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3, J Immunol, 170, 2170, 10.4049/jimmunol.170.4.2170 Irani, 2011, Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis, Ann Neurol, 69, 892, 10.1002/ana.22307 Irani, 2010, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia, Brain, 133, 2734, 10.1093/brain/awq213 Arino, 2016, Anti-LGI1-associated cognitive impairment: presentation and long-term outcome, Neurology, 87, 759, 10.1212/WNL.0000000000003009 van Sonderen, 2016, Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up, Neurology, 87, 1449, 10.1212/WNL.0000000000003173 Bastiaansen, 2017, Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies), Curr Opin Neurol, 30, 302, 10.1097/WCO.0000000000000444 Fukata, 2006, Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission, Science, 313, 1792, 10.1126/science.1129947 Yamagata, 2018, Structural basis of epilepsy-related ligand-receptor complex LGI1-ADAM22, Nat Commun, 9, 1546, 10.1038/s41467-018-03947-w Lovero, 2015, The LGI1-ADAM22 protein complex directs synapse maturation through regulation of PSD-95 function, Proc Natl Acad Sci U S A, 112, E4129, 10.1073/pnas.1511910112 Miller, 2017, Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis, Brain, 140, 1212, 10.1093/brain/awx070 Aysit-Altuncu, 2018, Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study, Neuroreport, 29, 932, 10.1097/WNR.0000000000001055 Ohkawa, 2013, Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors, J Neurosci, 33, 18161, 10.1523/JNEUROSCI.3506-13.2013 Thompson, 2018, The importance of early immunotherapy in patients with faciobrachial dystonic seizures, Brain, 141, 348, 10.1093/brain/awx323 Seagar, 2017, LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels, Proc Natl Acad Sci U S A, 114, 7719, 10.1073/pnas.1618656114 Lancaster, 2019, ADAM23 is a negative regulator of Kv1.1/Kv1.4 potassium currents, Neurosci Lett, 704, 159, 10.1016/j.neulet.2019.04.012 Petit-Pedrol, 2018, LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory, Brain, 141, 3144 Lalic, 2011, Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission, Epilepsia, 52, 121, 10.1111/j.1528-1167.2010.02756.x Yu, 2010, Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability, Hum Mol Genet, 19, 1702, 10.1093/hmg/ddq047 Lancaster, 2011, Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia, Ann Neurol, 69, 303, 10.1002/ana.22297 Vincent, 2010, Caspr2 antibodies in patients with thymomas, J Thorac Oncol, 5, S277, 10.1097/JTO.0b013e3181f23f04 Vale, 2017, Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies, Lancet, 389, 1367, 10.1016/S0140-6736(16)31459-3 van Sonderen, 2017, The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis, Nat Rev Neurol, 13, 290, 10.1038/nrneurol.2017.43 van Sonderen, 2016, The clinical spectrum of Caspr2 antibody-associated disease, Neurology, 87, 521, 10.1212/WNL.0000000000002917 Joubert, 2016, Characterization of a subtype of autoimmune encephalitis with anti-Contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures, JAMA Neurol., 73, 1115, 10.1001/jamaneurol.2016.1585 Sunwoo, 2015, Clinical manifestations of patients with CASPR2 antibodies, J Neuroimmunol, 281, 17, 10.1016/j.jneuroim.2015.03.005 Klein, 2013, Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping, JAMA Neurol, 70, 229, 10.1001/jamaneurol.2013.592 Bien, 2017, Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome, Eur J Neurol, 24, 175, 10.1111/ene.13180 Somers, 2011, Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity, J Neuropsychiatry Clin Neurosci, 23, 425, 10.1176/jnp.23.4.jnp425 Poliak, 1999, Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels, Neuron, 24, 1037, 10.1016/S0896-6273(00)81049-1 Scott, 2019, Loss of Cntnap2 causes axonal excitability deficits, developmental delay in cortical myelination, and abnormal stereotyped motor behavior, Cerebral Cortex, 29, 586, 10.1093/cercor/bhx341 Dawes, 2018, Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability, Neuron, 97, 806, 10.1016/j.neuron.2018.01.033 Patterson, 2018, Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia, Ann Neurol, 83, 40, 10.1002/ana.25120 Pinatel, 2015, Inhibitory axons are targeted in hippocampal cell culture by anti-Caspr2 autoantibodies associated with limbic encephalitis, Front Cell Neurosci, 9, 265, 10.3389/fncel.2015.00265 Saint-Martin, 2019, Impact of anti-CASPR2 autoantibodies from patients with autoimmune encephalitis on CASPR2/TAG-1 interaction and Kv1 expression, J Autoimmun, 103, 102284, 10.1016/j.jaut.2019.05.012 Fernandes, 2019, Disrupted AMPA receptor function upon genetic- or antibody-mediated loss of autism-associated CASPR2, Cereb Cortex, 12, 4919, 10.1093/cercor/bhz032 Giannoccaro, 2019, Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies, Brain, 142, 2000, 10.1093/brain/awz119 Becker, 2012, Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia, J Neurol Neurosurg Psychiatry, 83, 437, 10.1136/jnnp-2011-301506 Davies, 2010, GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries, Cell Metab, 12, 42, 10.1016/j.cmet.2010.04.016 Mysling, 2016, The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain, eLife, 5 Mysling, 2016, The angiopoietin-like protein ANGPTL4 catalyzes unfolding of the hydrolase domain in lipoprotein lipase and the endothelial membrane protein GPIHBP1 counteracts this unfolding, eLife, 5 Eguchi, 2019, GPIHBP1 autoantibody syndrome during interferon beta1a treatment, J Clin Lipidol, 13, 62, 10.1016/j.jacl.2018.10.004 Keri, 2019, Primary membranous nephropathy: comprehensive review and historical perspective, Postgrad Med J, 95, 23, 10.1136/postgradmedj-2018-135729 Cattran, 2017, Membranous nephropathy: integrating basic science into improved clinical management, Kidney Int, 91, 566, 10.1016/j.kint.2016.09.048 Doi, 1984, Distribution of IgG subclasses in membranous nephropathy, Clin Exp Immunol, 58, 57 De Vriese, 2017, A proposal for a serology-based approach to membranous nephropathy, J Am Soc Nephrol, 28, 421, 10.1681/ASN.2016070776 Beck, 2009, M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, 361, 11, 10.1056/NEJMoa0810457 Cheng, 2019, Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: clinical value assessment, Clin Chim Acta, 490, 135, 10.1016/j.cca.2018.12.027 Murtas, 2012, Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy, Clin J Am Soc Nephrol, 7, 1394, 10.2215/CJN.02170312 Zhang, 2019, A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor, Medicine (Baltimore), 98 Hofstra, 2012, Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy, J Am Soc Nephrol, 23, 1735, 10.1681/ASN.2012030242 Garcia-Vives, 2019, Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis, Lupus, 28, 396, 10.1177/0961203319828521 Al-Rabadi, 2018, Concurrent presentation of thrombotic thrombocytopenic Purpura and membranous nephropathy, Kidney Int Rep, 3, 476, 10.1016/j.ekir.2017.08.005 Huang, 2013, IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression, Mod Pathol, 26, 799, 10.1038/modpathol.2012.237 Salant, 2019, Unmet challenges in membranous nephropathy, Curr Opin Nephrol Hypertens, 28, 70, 10.1097/MNH.0000000000000459 Lambeau, 1999, Receptors for a growing family of secreted phospholipases A2, Trends Pharmacol Sci, 20, 162, 10.1016/S0165-6147(99)01300-0 Sukocheva, 2019, Current insights into functions of phospholipase A2 receptor in normal and cancer cells: more questions than answers, Semin Cancer Biol, 56, 116, 10.1016/j.semcancer.2017.11.002 Fresquet, 2017, PLA2R binds to the annexin A2-S100A10 complex in human podocytes, Sci Rep, 7, 6876, 10.1038/s41598-017-07028-8 Bharadwaj, 2013, Annexin A2 heterotetramer: structure and function, Int J Mol Sci, 14, 6259, 10.3390/ijms14036259 Fresquet, 2015, Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy, J Am Soc Nephrol, 26, 302, 10.1681/ASN.2014050502 Kao, 2015, Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy, J Am Soc Nephrol, 26, 291, 10.1681/ASN.2013121315 Skoberne, 2014, Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen, Eur J Clin Invest, 44, 753, 10.1111/eci.12292 Jurgensen, 2014, Complex determinants in specific members of the mannose receptor family govern collagen endocytosis, J Biol Chem, 289, 7935, 10.1074/jbc.M113.512780 Beck, 2017, PLA2R and THSD7A: disparate paths to the same disease?, J Am Soc Nephrol, 28, 2579, 10.1681/ASN.2017020178 Chi, 2019, The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy, J Formos Med Assoc, 118, 898, 10.1016/j.jfma.2018.12.026 Zhang, 2018, Clinical and prognostic significance of glomerular C1q deposits in primary MN, Clin Chim Acta, 485, 152, 10.1016/j.cca.2018.06.050 Hayashi, 2015, Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese, Clin Exp Nephrol, 19, 797, 10.1007/s10157-014-1064-0 Debiec, 2012, Recurrent membranous nephropathy in an allograft caused by IgG3kappa targeting the PLA2 receptor, J Am Soc Nephrol, 23, 1949, 10.1681/ASN.2012060577 Haddad, 2017, An in vitro model of idiopathic membranous nephropathy reveals PLA2R- and complement-dependent pathways of podocyte injury, J Am Soc Nephrol, 20, 109A Hayashi, 2018, Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy, Nephrol Dial Transplant, 33, 832, 10.1093/ndt/gfx235 Bally, 2016, Phospholipase A2 receptor-related membranous nephropathy and Mannan-binding lectin deficiency, J Am Soc Nephrol, 27, 3539, 10.1681/ASN.2015101155 Michalski, 2015, Primary Ficolin-3 deficiency--is it associated with increased susceptibility to infections?, Immunobiology, 220, 711, 10.1016/j.imbio.2015.01.003 Dekkers, 2018, Novel concepts of altered immunoglobulin G Galactosylation in autoimmune diseases, Front Immunol, 9, 553, 10.3389/fimmu.2018.00553 Foster, 2016, Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes, Am J Physiol Renal Physiol, 311, F487, 10.1152/ajprenal.00275.2016 Luo, 2018, Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy, Front Immunol, 9, 1433, 10.3389/fimmu.2018.01433 Hoxha, 2017, An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy, J Am Soc Nephrol, 28, 520, 10.1681/ASN.2016010050 Stoddard, 2019, Structure and function insights garnered from in silico modeling of the thrombospondin type-1 domain-containing 7A antigen, Proteins, 87, 136, 10.1002/prot.25640 Seifert, 2018, The most N-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-associated membranous nephropathy, J Am Soc Nephrol, 29, 1536, 10.1681/ASN.2017070805 Herwig, 2019, Thrombospondin type 1 domain-containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes, J Am Soc Nephrol, 30, 824, 10.1681/ASN.2018090941 Iwakura, 2015, Prevalence of enhanced granular expression of thrombospondin Type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy, PLoS One, 10, 10.1371/journal.pone.0138841 Tomas, 2014, Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, 371, 2277, 10.1056/NEJMoa1409354 Kronbichler, 2017, Recent Progress in deciphering the Etiopathogenesis of primary membranous nephropathy, Biomed Res Int, 2017, 1936372, 10.1155/2017/1936372 Wang, 2017, Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy, Clin J Am Soc Nephrol, 12, 1642, 10.2215/CJN.01460217 Hoxha, 2016, A mechanism for Cancer-associated membranous nephropathy, N Engl J Med, 374, 1995, 10.1056/NEJMc1511702 Tomas, 2016, Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, 126, 2519, 10.1172/JCI85265 Tomas, 2017, A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy, J Am Soc Nephrol, 11, 3262, 10.1681/ASN.2017010030 Wang, 2018, Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway, Biosci Rep, 38 Goletz, 2019, A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid, Br J Dermatol, 180, 149, 10.1111/bjd.17202 Verrando, 1991, Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa, Lab Invest, 64, 85 Giurdanella, 2019, Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases, Br J Dermatol, 2, 373 Chan, 1997, Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid, J Invest Dermatol, 108, 848, 10.1111/1523-1747.ep12292578 Domloge-Hultsch, 1992, Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease, J Clin Invest, 90, 1628, 10.1172/JCI116033 Lazarova, 2008, IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid, J Am Acad Dermatol, 58, 951, 10.1016/j.jaad.2008.02.035 Egan, 2001, Anti-epiligrin cicatricial pemphigoid and relative risk for cancer, Lancet, 357, 1850, 10.1016/S0140-6736(00)04971-0 Matsushima, 2004, A case of anti-epiligrin cicatricial pemphigoid associated with lung carcinoma and severe laryngeal stenosis: review of Japanese cases and evaluation of risk for internal malignancy, J Dermatol, 31, 10, 10.1111/j.1346-8138.2004.tb00497.x Leverkus, 1999, Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?, Arch Dermatol, 135, 1091, 10.1001/archderm.135.9.1091 Terra, 2011, Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients, Br J Dermatol, 165, 815, 10.1111/j.1365-2133.2011.10474.x La Placa, 2019, Mucous membrane pemphigoid-associated malignancies: case series and a brief overview of the literature, Dermatol Pract Concept, 9, 119, 10.5826/dpc.0902a07 Carter, 1991, Epiligrin, a new cell adhesion ligand for integrin alpha 3 beta 1 in epithelial basement membranes, Cell, 65, 599, 10.1016/0092-8674(91)90092-D Rousselle, 1991, Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments, J Cell Biol, 114, 567, 10.1083/jcb.114.3.567 Koga, 2019, Detachment of keratinocytes at the basement membrane zone caused by inhibitory effect of the antibodies from sera of mucous membrane pemphigoid patients, J Dermatol, 46, 1046, 10.1111/1346-8138.15083 Lazarova, 2000, Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model, J Invest Dermatol, 114, 178, 10.1046/j.1523-1747.2000.00829.x Delmont, 2017, Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy, Brain, 140, 1851, 10.1093/brain/awx124 Lin, 2018, Presence of both anti-contactin 1 and anti-neurofascin 140 antibodies in a case of chronic inflammatory demyelinating polyneuropathy, eNeurologicalSci, 13, 38, 10.1016/j.ensci.2018.11.016 Segelmark, 2018 Thibaud, 2019, Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report, BMC Nephrol, 20, 6, 10.1186/s12882-018-1197-6 Lerner, 1967, The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis, J Exp Med, 126, 989, 10.1084/jem.126.6.989 Ohlsson, 2014, Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease, Am J Kidney Dis, 63, 289, 10.1053/j.ajkd.2013.08.032 Sethi, 2007, Linear anti-glomerular basement membrane IgG but no glomerular disease: Goodpasture’s syndrome restricted to the lung, Nephrol Dial Transplant, 22, 1233, 10.1093/ndt/gfl841 Cui, 2007, Antiglomerular basement membrane disease with normal renal function, Kidney Int, 72, 1403, 10.1038/sj.ki.5002525 Qu, 2013, The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease, BMC Immunol, 14, 19, 10.1186/1471-2172-14-19 Bruschi, 2011, Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens, J Proteomics, 74, 2008, 10.1016/j.jprot.2011.05.021 Prunotto, 2010, Autoimmunity in membranous nephropathy targets aldose reductase and SOD2, J Am Soc Nephrol, 21, 507, 10.1681/ASN.2008121259 Miles, 1991, Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor, Biochemistry, 30, 1682, 10.1021/bi00220a034 Kimura, 2017, Circulating antibodies to alpha-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy, Clin Exp Nephrol, 21, 117, 10.1007/s10157-016-1235-2 Aarli, 2008, Myasthenia gravis in the elderly: is it different?, Ann N Y Acad Sci, 1132, 238, 10.1196/annals.1405.040 Zillikens, 1996, A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone, J Invest Dermatol, 106, 1333, 10.1111/1523-1747.ep12349283 Chen, 1996, Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen, Br J Dermatol, 134, 340, 10.1111/j.1365-2133.1996.tb07625.x Kridin, 2019, Anti-p200 pemphigoid: a systematic review, Front Immunol, 10, 2466, 10.3389/fimmu.2019.02466 Patsatsi, 2017, Chronic bullous disease of childhood with IgG reactivity to p200 antigen, Int J Dermatol, 56, 773, 10.1111/ijd.13616 Zillikens, 1996, A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone, J Invest Dermatol, 106, 465, 10.1111/1523-1747.ep12343631 Shimanovich, 2003, The autoantigen of anti-p200 pemphigoid is an acidic noncollagenous N-linked glycoprotein of the cutaneous basement membrane, J Invest Dermatol, 121, 1402, 10.1111/j.1523-1747.2003.12609.x Wald, 2019, Overlap of bullous, anti-Laminin-332, and anti-p200 pemphigoid with concomitant anti-Contactin-1-positive inflammatory polyneuropathy treated with intravenous immunoglobulins as a manifestation of epitope spreading, JAMA Dermatol, 155, 631, 10.1001/jamadermatol.2018.5536 Dainichi, 2010, From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid, J Dermatol, 37, 231, 10.1111/j.1346-8138.2009.00793.x Dainichi, 2009, Anti-laminin gamma-1 pemphigoid, Proc Natl Acad Sci U S A, 106, 2800, 10.1073/pnas.0809230106 Groth, 2011, Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid, Br J Dermatol, 164, 76, 10.1111/j.1365-2133.2010.10056.x Monshi, 2012, A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading, Br J Dermatol, 167, 1179, 10.1111/j.1365-2133.2012.11076.x Vafia, 2012, Pathogenicity of autoantibodies in anti-p200 pemphigoid, PLoS One, 7, 10.1371/journal.pone.0041769 Koga, 2013, An attempt to develop mouse model for anti-laminin gamma1 pemphigoid, J Dermatol Sci, 70, 108, 10.1016/j.jdermsci.2013.01.001 Lamprecht, 2018, Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated Vasculitides, Front Immunol, 9, 680, 10.3389/fimmu.2018.00680 Holland, 2004, Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass, Clin Exp Immunol, 138, 183, 10.1111/j.1365-2249.2004.02566.x Brouwer, 1991, Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders, Clin Exp Immunol, 83, 379, 10.1111/j.1365-2249.1991.tb05647.x Hussain, 2009, Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors, Immunology, 128, 236, 10.1111/j.1365-2567.2009.03108.x Chang, 2012, Increased IgG4-positive plasma cells in granulomatosis with Polyangiitis: a diagnostic pitfall of IgG4-related disease, Int J Rheumatol, 2012, 121702, 10.1155/2012/121702 Bando, 2015, A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis, Pituitary, 18, 722, 10.1007/s11102-015-0650-9 Kaushik, 2018, Medical mirroring: granulomatosis with polyangiitis (formerly Wegener's) mimicking immunoglobulin-G4 related disease, Int J Rheum Dis, 21, 885, 10.1111/1756-185X.12687 Della-Torre, 2016, Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature, Medicine (Baltimore), 95, 10.1097/MD.0000000000004633 Abbass, 2019, Granulomatosis with polyangiitis in a patient with biopsy-proven IgG4-related pulmonary disease and coincident small cell lung cancer, BMJ Case Rep, 12, 10.1136/bcr-2018-226280 Massey, 2017, IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies, Neurol Neuroimmunol Neuroinflam, 4, e341, 10.1212/NXI.0000000000000341 Watanabe, 2018, Rapidly progressive glomerulonephritis caused by overlap syndrome of IgG4-related tubulointerstitial nephritis and myeloperoxidase-antineutrophil cytoplasmic antibody-associated necrotising glomerulonephritis, Clin Exp Rheumatol, 36, 172 Su, 2017, Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: a case report, Medicine (Baltimore), 96, 10.1097/MD.0000000000006707 Touge, 2017, A case of proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive/IgG4-related lung disease, Respir Med Case Rep, 20, 92 Danlos, 2017, Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome, Autoimmun Rev, 16, 1036, 10.1016/j.autrev.2017.07.020 Perez Alamino, 2013, IgG4-associated vasculitis, Curr Rheumatol Rep, 15, 348, 10.1007/s11926-013-0348-9 Kawashima, 2019, Consideration concerning similarities and differences between ANCA-associated vasculitis and IgG-4-related diseases: case series and review of literature, Immunol Res, 67, 99, 10.1007/s12026-019-9070-7 Goulabchand, 2017, Comment on the article entitled “Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome”, Autoimmun Rev, 16, 1036, 10.1016/j.autrev.2017.07.020 Yoo, 2019, No overlap between IgG4-related disease and microscopic polyangiitis and granulomatosis with polyangiitis despite elevated serum IgG4 at diagnosis: a retrospective monocentric study, Clin Rheumatol, 38, 1147, 10.1007/s10067-018-4402-x Al-Soudi, 2019, IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study, Arthritis Res Ther, 21, 43, 10.1186/s13075-018-1806-6 Tominaga, 2018, Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis, BMC Nephrol, 19, 120, 10.1186/s12882-018-0922-5 Zou, 2015, Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center, Medicine (Baltimore), 94, 10.1097/MD.0000000000001472 Stump, 2019, Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII, Br J Dermatol, 4, 835, 10.1111/bjd.17923 Zheng, 2019, Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid, J Eur Acad Dermatol Venereol, 33, 595, 10.1111/jdv.15325 Diaz, 1990, Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome, J Clin Invest, 86, 1088, 10.1172/JCI114812 Stanley, 1981, Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia, Cell, 24, 897, 10.1016/0092-8674(81)90115-X Sitaru, 2007, The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases, Arch Dermatol Res, 299, 1, 10.1007/s00403-007-0734-0 Zhou, 2016, Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis, J Dermatol, 43, 141, 10.1111/1346-8138.13051 Liu, 1995, The role of complement in experimental bullous pemphigoid, J Clin Invest, 95, 1539, 10.1172/JCI117826 Chen, 2001, Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid, J Clin Invest, 108, 1151, 10.1172/JCI11494 Liu, 2000, A critical role for neutrophil elastase in experimental bullous pemphigoid, J Clin Invest, 105, 113, 10.1172/JCI3693 Hiroyasu, 2013, Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway, Am J Pathol, 182, 828, 10.1016/j.ajpath.2012.11.029 Iwata, 2009, IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment, J Invest Dermatol, 129, 919, 10.1038/jid.2008.305 Ujiie, 2014, Bullous pemphigoid autoantibodies directly induce blister formation without complement activation, J Immunol, 193, 4415, 10.4049/jimmunol.1400095 Zuo, 2016, IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid, J Autoimmun, 73, 111, 10.1016/j.jaut.2016.06.019 Boronat, 2013, Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels, Ann Neurol, 73, 120, 10.1002/ana.23756 Hara, 2017, DPPX antibody-associated encephalitis: Main syndrome and antibody effects, Neurology, 88, 1340, 10.1212/WNL.0000000000003796 Piepgras, 2015, Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons, Neurology, 85, 890, 10.1212/WNL.0000000000001907 Lutt, 2018, High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders, Neurogastroenterol Motil, 30, 10.1111/nmo.13292 Gelpi, 2016, Neuropathological criteria of anti-IgLON5-related tauopathy, Acta Neuropathol, 132, 531, 10.1007/s00401-016-1591-8 Cagnin, 2017, Microglial and neuronal TDP-43 pathology in anti-IgLON5-related Tauopathy, J Alzheimer’s Dis, 59, 13, 10.3233/JAD-170189 Sabater, 2014, A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study, Lancet Neurol, 13, 575, 10.1016/S1474-4422(14)70051-1 Schoberl, 2018, IgLON5: a case with predominant cerebellar tau deposits and leptomeningeal inflammation, Neurology, 91, 180, 10.1212/WNL.0000000000005859 Nagamine, 1997, Positional cloning of the APECED gene, Nat Genet, 17, 393, 10.1038/ng1297-393 Meyer, 2016, AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies, Cell, 166, 582, 10.1016/j.cell.2016.06.024 Kisand, 2010, Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines, J Exp Med, 207, 299, 10.1084/jem.20091669 Karner, 2016, IL-6-specific autoantibodies among APECED and thymoma patients, Immun Inflamm Dis, 4, 235, 10.1002/iid3.109 Bichele, 2018, IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model, Eur J Immunol, 48, 464, 10.1002/eji.201747209 Gavanescu, 2008, B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: a therapeutic approach for APECED patients, Proc Natl Acad Sci U S A, 105, 13009, 10.1073/pnas.0806874105 Ossart, 2018, Breakdown of immune tolerance in AIRE-deficient rats induces a severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy-like autoimmune disease, J Immunol, 201, 874, 10.4049/jimmunol.1701318